Endoscopic sleeve gastroplasty is cost saving versus semaglutide, finds study

For individuals with class II obesity, endoscopic sleeve gastroplasty (ESG) is cost saving compared with semaglutide, according to a study published online April 12 in JAMA Network Open.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup